Page 2 - Oral Solution News Today

The FDA recalled numerous products over safety concerns in April 2024.

Here are the food & beverage, pet product, and drug/medical device recalls by the US Food & Drug Administration.

Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal failureProof-of-concept studies of crofelemer for MVID and SBS planned for 2024 SAN FRANCISCO, CA / ACCESSWIRE / A...

Sonic Automotive, Inc. (SAH) Thursday reported a 12 percent decline in first quarter profit, as total revenues were down 3 percent. The U.S. automotive retailer's quarterly profit was $42, down from $47.

Sapropterin Dihydrochloride Powder for Oral Solution is indicated to reduce blood phenylalanine levels in patients with hyperphenylalaninemia due to tetrahydrobiopterin-responsive phenylketonuria.

Unilever (UN, ULVR.L, UL) reported first quarter underlying sales growth of 4.4%, with volume growth increasing to 2.2%. Turnover was 15.0 billion euros, up 1.4%, with 2.

While reporting financial results for the first quarter on Thursday, life sciences company Labcorp (LH) narrowed adjusted earnings and revenue growth guidance range for the full-year 2024.

Inchcape (INCH.L) reported first-quarter Group revenue of 2.3 billion pounds, with 5% reported growth. This reflected 6% organic growth and a 5% contribution from recent bolt-on acquisitions in APAC, offset by 6% translational currency headwinds.

Producer prices in Spain continued their steep falling trend in March amid cheaper energy prices, data from the statistical office INE showed on Thursday. The producer price index posted an annual decrease of 8.

While reporting financial results for the first quarter on Thursday, utility PG&E Corp. (PCG) raised its earnings guidance for the full-year 2024, while reaffirming core earnings outlook.